摘要
目的探讨经尿道钬激光前列腺剜除术治疗前列腺增生症的疗效及安全性。方法回顾性分析320例前列腺增生症接受经尿道钬激光前列腺剜除术患者的临床资料,对比其术前与术后1、6、12个月的IPSS症状评分、最大尿流率、残余尿量的变化。结果患者平均年龄(74.2±9.1)岁,术前前列腺平均体积(106.8±23.1)mL,平均切除前列腺组织重量(82.6±27.3)g,留置尿管平均时间(62.8±31.6)h。术后1、6、12个月的IPSS症状评分分别为7.0±2.6、6.2±2.5、6.0±2.5、最大尿流率分别为(21.2±7.5、24.5±5.1、25.6±4.6)mL/s、残余尿量分别为(46.0±9.9、41.3±7.9、38.3±8.7)mL,均较术前改善明显(P<0.05)。结论经尿道钬激光前列腺剜除术治疗前列腺增生彻底、安全、有效,患者恢复快,痛苦小,可作为当代治疗BPH的"白金"标准。
Objective To investigate the efficacy and safety of transurethral holmium laser prostate enucleation on benign prostatic hyperplasia. Methods The clinical data of 320 patients with benign prostatic hyperplasia who received transurethral holmium laser prostate enucleation were retrospectively analyzed, and the changes of IPSS, maximum flow rate and residual urine volume before treatment and I month, 6 months and 12 months after treatment were compared. Results The average age of patients was （74.2±9.1）years, the average prostate volume before treatment was （106.8±23.1）mL, the average weight of prostate tissue resected was （82.65±27.3）g, and the average time of urinary catheter indwelling was （62.8±31.6）h. IPSS, the maximum urine flow rate and the volume of residual urine 1 month, 6 months and 12 months after treatment were 7.0±2.6, 21.2±7.5, 46.0±9.9; 6.2±2.5, 24.5±5.1, 41.34±7.9; 6.0±2.5, 25.6±4.6, 38.3±8.7, which were significantly improved. Conclusions It＇s safe and effective to treat benign prostatic hyperplasia with transurethral holmium laser prostate enucleation. The patients can recover fast with little pain.
出处
《现代泌尿外科杂志》
CAS
2013年第1期58-59,88,共3页
Journal of Modern Urology
关键词
钬激光
良性前列腺增生
外科手术
残余尿量
疗效
holmium laser
benign prostatic hyperplasia
surgical operation
residual urine volume
efficacy
safety
